COR today
$352.60+$3.22 (+0.92%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bullish
1 hourSymmetric Triangle
15 minAscending Triangle
5 minConsolidating
Daily trend turns down below $320.06
Key levels
Resistance$376.92
Resistance$363.95
Support$345.00
Support$332.67
Latest news & SEC filings
SEC FilingCencora, Inc. filed an insider trading report (Form 4)
AnalystJP Morgan keeps Overweight on Cencora, lifts price target to $413
All COR news →About Cencora
Cencora is a pharmaceutical distribution company that supplies drugs and other healthcare products to pharmacies, hospitals, and providers. It also offers specialty distribution and related services to manufacturers and healthcare organizations. The company operates mainly in the United States and Europe.
Based on the company's 10-K filed Nov 25, 2025.
NYSE · Healthcare
Cencora, Inc. (COR)
What Is the Price Target for COR?
SEPT Low Target
$285.00
SEPT Mid Target
$380.00
SEPT High Target
$413.00
Analyst Consensus
$380.00
Is COR a Buy or Sell Right Now?
Thesis
- •Revenue growing 9.3% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for COR.
Start Free Trial →Is COR Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$316.27
34
Moat Score
NONE
6/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with COR?
Insider Signal
NEUTRAL
1 buys / 3 sells (90d)
Congress Signal
BUYING
3 buys / 3 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Campbell Elizabeth S | officer | Buy | 1,830 | - | Nov 6, 2026 |
| Campbell Elizabeth S | officer | Sale | 846 | $282K | Nov 6, 2026 |
| Mauch Robert P. | director officer | Buy | 4,066 | - | Nov 6, 2026 |
| Mauch Robert P. | director officer | Sale | 1,673 | $558K | Nov 6, 2026 |
| Krikorian Lazarus | officer | Buy | 1,398 | - | Nov 6, 2026 |
| Krikorian Lazarus | officer | Sale | 576 | $192K | Nov 6, 2026 |
| Krikorian Lazarus | officer | Sale | 986 | $326K | Nov 2, 2026 |
| Tyler Lauren M | director | Buy | 91 | $30K | Oct 30, 2026 |
| NALLY DENNIS M | director | Buy | 106 | $35K | Oct 30, 2026 |
| Verma Pawan | officer | Buy | 8,538 | - | Oct 30, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →COR Growth Story
Revenue YoY
9.3%
3yr Revenue CAGR
10.4%
EPS Growth YoY
5.71%
FCF Growth YoY
7.0%
Revenue Trend
STABLE
Dark Pool Trades for COR
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for COR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:58:55 | $349.38 | 11,144 | $$3.9M | BUY |
| 21:23:32 | $349.38 | 1,430 | $$500K | BUY |
| 21:00:43 | $349.38 | 1,193 | $$417K | BUY |
| 21:00:43 | $349.38 | 2,160 | $$755K | BUY |
| 21:00:43 | $349.38 | 6,680 | $$2.3M | BUY |
5 dark pool trades shown · $$7.9M preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About COR
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for COR. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
$COR declared a quarterly dividend of $0.66. Ex-date is Fri Nov 13, with payment on Mon Nov 30. 💵
Zone Setup -- $COR (Cencora, Inc.) Price: $307.90 | Zone: $306.41 to $313.90 Conviction: HIGH | Analyst upside: +10.1% Major volume event today — setup forming. Earnings: EPS_BEAT. Earnings beat: EP...
Join 3,500+ traders discussing COR in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Cencora, Inc. (COR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →COR — frequently asked questions
What is COR stock price today?
Cencora, Inc. (COR) is at $352.60, up 0.92% (+$3.22) at the Nov 13, 2026 close.
Why is COR stock moving today?
Latest COR news — Nov 10, 2026: Cencora, Inc. filed an insider trading report (Form 4) · Nov 10, 2026: JP Morgan keeps Overweight on Cencora, lifts price target to $413
What is the COR price target?
The average analyst price target for COR is $380.00, ranging from $285 to $413, based on 13 analysts. Latest: JP Morgan maintains on Nov 10, 2026.
What do analysts rate COR?
Analyst ratings for COR: 0 Buy, 24 Hold, 0 Sell — consensus Hold.
Did COR beat earnings?
COR last reported on Nov 4, 2026: EPS $4.66 vs $4.58 expected — a beat of 1.7%.
What is COR's P/E ratio?
COR trades at a P/E of 25.9 vs a Healthcare average of 17.1.
Does COR pay a dividend?
Yes. COR's dividend yield is 0.72%.
How much debt does COR have?
Cencora, Inc. reported $11.7B of debt and $2.8B of cash (Jun 30, 2026).
What are COR support and resistance levels?
Support: $345.00, $332.67, $320.06. Resistance: $363.95, $376.92.
What are insiders doing with COR?
Insider activity: NEUTRAL, 1 buys and 3 sells in the last 90 days.
What is the latest news on COR?
Nov 10, 2026: Cencora, Inc. filed an insider trading report (Form 4) · Nov 10, 2026: JP Morgan keeps Overweight on Cencora, lifts price target to $413